NCT04389632 2026-03-16A Study of Sigvotatug Vedotin in Advanced Solid TumorsSeagen Inc.Phase 1 Recruiting1,006 enrolled
NCT07023731 2026-02-19A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationArvinas Inc.Phase 1/2 Recruiting159 enrolled
NCT07334119 2026-02-19Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid TumorsMyeloid TherapeuticsPhase 1 Recruiting60 enrolled
NCT07182149 2026-02-12A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid TumorsNormunity AccelCo, Inc.Phase 1 Recruiting150 enrolled
NCT06549816 2025-12-15A Study of SGN-B6A in Chinese Participants With Advanced Solid TumorsSeagen Inc.Phase 1 Completed6 enrolled
NCT03983954 2025-11-28Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.NeoTX Therapeutics Ltd.Phase 1 Active not recruiting120 enrolled
NCT05252416 2025-11-28(VELA) Study of BLU-222 in Advanced Solid TumorsBlueprint Medicines CorporationPhase 1 Terminated50 enrolled
NCT00101972 2022-02-22RAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaMacroGenicsPhase 1 Completed53 enrolled